Bausch & Lomb Corp (BLCO) Stock Price, Quote & News

Company Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeut...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 905-695-7700

Website: www.bausch.com

Address:

520 Applewood Crescent, Vaughan, Canada

vcd103 Oct. 26 at 1:08 AM

$BHC $BLCO RBC had this interesting comment on potential sale timing.. RBC Capital has reiterated its Market Perform rating and US$10 price target on Bausch Health Companies (BHC.NaE) ahead of its third-quarter results. Analyst Douglas Miehm estimates third quarter revenue of US$2.65 billion (vs. cons. US$2.62 billion). Key areas of focus include updates on the ongoing Xifaxan patent litigation and potential policy-related headwinds, Miehm notes. "Additionally, we will look for commentary on management's strategic vision for the BLCO asset. In our view, should a sale of the asset materialize, it would most likely occur in the 2026/2027 time frame."

1 · Reply

CindyH0o Oct. 24 at 7:27 AM

$BHC jaw dropping. J. Paulson latest filing of BHC ownership. $BLCO

2 · Reply

ChubbRock999 Oct. 22 at 11:57 AM

$BHC if $COO and $BLCO were to merge, would BHC have to approve it?

1 · Reply

smartoptionstrader Oct. 20 at 6:14 PM

ACTIVIST ALERT: Jana Partners took a stake in $COO demanding a breakup or merger with $BLCO. Stock popped 6%+ but could be just the start. Jana has a 30% annual return track record forcing value-unlocking deals. Bausch + Lomb's CEO already endorsed the merger publicly—rare and bullish. $COO trades at $75 after holding critical support at $61.77, with technical resistance at $112-$116. Historical activist campaigns generate 30-50% premiums. Options traders positioning in 3-6 month calls as implied volatility spikes. Risk-reward heavily favors bulls here. Cooper Companies (COO) Monthly Chart from Barchart - Shows the bearish trend reversal at critical support ($61.77 near October 2022 low of $61.05), recent recovery to $75+, and technical resistance levels at September 2024 high ($112.38) and September 2021 record peak ($115.90). The chart illustrates the significant upside potential from current levels to previous highs.

0 · Reply

topstockalerts Oct. 20 at 12:41 PM

Cooper Cos. Stock Rises on Jana Partners' Activist Push Cooper Cos. saw its stock rise over 4% before market open on Monday after the Wall Street Journal reported that activist investor Jana Partners has built a stake in the company and plans to push for strategic alternatives, including potentially merging its contact lens unit with rival Bausch + Lomb. Jana believes the two business units of Cooper lack synergies and will advocate for changes to improve stock performance through better capital allocation and returns. The size of Jana's stake was not disclosed. The activist plan is already supported by Bausch + Lomb CEO Brent Saunders, who expressed interest in the potential merger in an interview. Cooper operates through two segments: CooperVision, a leading producer of soft contact lenses, and CooperSurgical, which provides women's health and fertility products and services. $COO $BLCO

0 · Reply

EarlyBirdEmail Oct. 20 at 10:45 AM

$DOGE.X $COO $BLCO $PPRUY $LRLCY Some renewed buzz surrounding Elon Musk’s X platform and Dogecoin sent the price of the cryptocurrency up about 3% on Sunday. https://www.earlybird.email/p/dogecoin-new-elon-musk-buzz

0 · Reply

Tokenist Oct. 20 at 10:14 AM

$COO popping premarket — up 6% after activist fund Jana Partners took a stake in The Cooper Companies and started pushing for big changes. 💣 Jana wants a strategic review, calling for Cooper to split its businesses, the contact lens giant CooperVision and the women’s health unit CooperSurgical — saying the combo has dragged down shareholder returns. 👀 Rumors are swirling that $BLCO (Bausch + Lomb) CEO Brent Saunders is open to merging the contact lens divisions, potentially creating a major new player in the eye care market. 📈 After lagging hard this year (-21% YTD), investors are betting Jana’s involvement could unlock serious value. Analysts have a $79.45 PT, about 10% upside, but a merger or breakup could change that fast. 💬 $COO last traded at $76.50, and traders are watching closely — this could be the start of an activist-fueled comeback story.

1 · Reply

DonCorleone77 Oct. 20 at 2:13 AM

$COO $BLCO From The Wall Street Journal: "Activist Jana Takes Stake in Cooper, a Maker of Medical Devices" -- Bausch + Lomb is considered a potential partner for contact-lens unit, and CEO says he would be interested https://www.wsj.com/business/deals/activist-jana-takes-stake-in-cooper-a-maker-of-medical-devices-20ffbe9c?mod&#61;hp_lead_pos6

0 · Reply

StocktwitsNews Oct. 20 at 1:25 AM

Activist Investor Turns Up Heat On Cooper, Urges Bausch + Lomb Merger To Boost Returns: Report $COO $BLCO https://stocktwits.com/news/equity/markets/activist-investor-turns-up-heat-on-cooper-urges-bausch-lomb-merger-to-boost-returns-report/ch6CWJvR3oK

0 · Reply

kbingo12 Oct. 20 at 12:40 AM

$BLCO Exclusive: Jana Partners has a stake in medical-devices maker Cooper and plans to urge a deal to combine its contact-lens unit with rival Bausch + Lomb.

0 · Reply

Activist Jana Takes Stake in Cooper, a Maker of Medical Devices

COO

Sep 29, 2025, 7:15 AM EDT - 4 weeks ago

Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13

Sep 8, 2025, 2:37 PM EDT - 7 weeks ago

Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 8, 2025, 7:00 AM EDT - 7 weeks ago

Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States

Aug 18, 2025, 5:01 PM EDT - 2 months ago

Bausch + Lomb Announces Board Changes

Aug 14, 2025, 7:15 AM EDT - 2 months ago

Bausch + Lomb to Participate in Upcoming Investor Conferences

Jul 30, 2025, 9:33 PM EDT - 3 months ago

Bausch + Lomb Corporation (BLCO) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 6:57 AM EDT - 3 months ago

Bausch + Lomb Announces Second-Quarter 2025 Results

Jul 1, 2025, 7:00 AM EDT - 4 months ago

Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye

Jun 30, 2025, 6:58 AM EDT - 4 months ago

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

Jun 18, 2025, 4:30 PM EDT - 4 months ago

Bausch + Lomb Announces Pricing of Upsized Senior Secured Notes Offering

Jun 17, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb Corporation (BLCO) And Encourages Investors to Connect

Jun 16, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb Corporation (BLCO) Stockholders to Inquire about Securities Investigation

Jun 15, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bausch + Lomb Corporation (BLCO) and Encourages Investors to Learn More About the Investigation

Jun 13, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb Corporation (BLCO) And Encourages Investors to Reach Out

Jun 12, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb Corporation (BLCO) And Encourages Stockholders to Reach Out

Jun 11, 2025, 10:02 AM EDT - 4 months ago

BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm

Jun 11, 2025, 10:00 AM EDT - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb Corporation (BLCO) And Encourages Stockholders to Connect

Jun 10, 2025, 10:00 AM EDT - 4 months ago

Bausch + Lomb Corporation (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jun 10, 2025, 8:48 AM EDT - 4 months ago

Bausch + Lomb Announces Launch of Senior Secured Notes Offering and Refinancing of Credit Agreement

Jun 9, 2025, 12:00 PM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bausch + Lomb Corporation (BLCO) and Encourages Stockholders to Learn More About the Investigation

May 22, 2025, 7:30 AM EDT - 5 months ago

Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference

May 21, 2025, 4:30 PM EDT - 5 months ago

Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results

Apr 30, 2025, 11:02 AM EDT - 6 months ago

Bausch + Lomb Corporation (BLCO) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 6:57 AM EDT - 6 months ago

Bausch + Lomb Announces First-Quarter 2025 Results

Apr 24, 2025, 7:00 AM EDT - 6 months ago

Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall

Apr 11, 2025, 10:00 AM EDT - 7 months ago

Bausch + Lomb (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb (BLCO) Shareholders to Inquire about Securities Investigation

Apr 9, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb (BLCO) And Encourages Shareholders to Connect

Apr 8, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb (BLCO) And Encourages Shareholders to Reach Out

Apr 7, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bausch + Lomb (BLCO) and Encourages Investors to Learn More About the Investigation

Apr 6, 2025, 10:00 AM EDT - 7 months ago

Bausch + Lomb (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 4, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Bausch + Lomb (BLCO) And Encourages Investors to Connect

Apr 3, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb (BLCO) Stockholders to Inquire about Securities Investigation

Apr 2, 2025, 10:00 AM EDT - 7 months ago

Bausch + Lomb (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 1, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Bausch + Lomb (BLCO) and Encourages Stockholders to Learn More About the Investigation

Mar 31, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb (BLCO) Investors to Inquire about Securities Investigation

Mar 30, 2025, 10:00 AM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb (BLCO) And Encourages Investors to Reach Out

Mar 28, 2025, 1:30 PM EDT - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Bausch + Lomb (BLCO) And Encourages Stockholders to Reach Out

Mar 26, 2025, 7:45 AM EDT - 7 months ago

Bausch + Lomb Will Release First-Quarter 2025 Financial Results on April 30

Feb 19, 2025, 12:19 PM EST - 8 months ago

Bausch + Lomb Corporation (BLCO) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 9:16 AM EST - 8 months ago

Bausch & Lomb to shake up contact lenses with deal off the table

Feb 6, 2025, 7:05 AM EST - 9 months ago

Bausch Health Provides Update on Strategic Alternatives

BHC

vcd103 Oct. 26 at 1:08 AM

1 · Reply

CindyH0o Oct. 24 at 7:27 AM

$BHC jaw dropping. J. Paulson latest filing of BHC ownership. $BLCO

2 · Reply

ChubbRock999 Oct. 22 at 11:57 AM

$BHC if $COO and $BLCO were to merge, would BHC have to approve it?

1 · Reply

smartoptionstrader Oct. 20 at 6:14 PM

0 · Reply

topstockalerts Oct. 20 at 12:41 PM

0 · Reply

EarlyBirdEmail Oct. 20 at 10:45 AM

0 · Reply

Tokenist Oct. 20 at 10:14 AM

1 · Reply

DonCorleone77 Oct. 20 at 2:13 AM

0 · Reply

StocktwitsNews Oct. 20 at 1:25 AM

0 · Reply

kbingo12 Oct. 20 at 12:40 AM

$BLCO Exclusive: Jana Partners has a stake in medical-devices maker Cooper and plans to urge a deal to combine its contact-lens unit with rival Bausch + Lomb.

0 · Reply

BEATOFtheMARKET Oct. 9 at 5:34 PM

Results of list 9/26/25 $BLCO $BLD $BLDR $BLFS The list has 1 more day to go tomorrow. After an audit of 400 calls 291 hit the targets that's an 72.9% accuracy for the first 400 calls there is way more calls in the sheet any one that will want access to the Google sheet can sent me a private message and you can audit the rest of the Google sheet your self. 🔥 Cycle Trading Signal plugged into AI 🔥 list. @Stocktwits

0 · Reply

JarvisFlow Oct. 7 at 4:32 PM

Evercore ISI Group has updated their rating for Bausch & Lomb ( $BLCO ) to Outperform with a price target of 17.

0 · Reply

WallStreetBuyDip Oct. 6 at 12:02 AM

$BLCO Massive volume increase with 811,100 shares traded on Oct 1 compared to the 699,116 average volume. Price moved from $14.67 to $15.20. Smart move to wait for a lower H% before considering entry.

0 · Reply

SlowDriver Oct. 1 at 6:53 PM

$BHC $BLCO are we up today because the government shut down? Does this stop, or delay, the Inflation Reduction Act from moving ahead?

0 · Reply

JarvisFlow Oct. 1 at 5:50 PM

Goldman Sachs has adjusted their stance on Bausch & Lomb ( $BLCO ), setting the rating to Neutral with a target price of 16.

0 · Reply

BW69 Sep. 3 at 2:24 PM

$BHC $BLCO 88% not 80%!

0 · Reply

vcd103 Aug. 30 at 11:48 AM

$BHC in the beginning of the year i felt that we might see some progress on the spinoff that has become stalled-off through deregulation and perhaps an uptick in M&A. However, the replacement of major health care agencies wth kooks, bls firngs, indiscriminate tariffs (this company is Canadian), etc make such scenario unlikely. Nor do i see anybway how $BLCO gets back to its IPO price anytime soon. I will still hold on my shares .. perhaps the freaking stalled-off can be unwound and these companies are put back together..

1 · Reply

omar_progressivetrading Aug. 3 at 9:11 PM

$BLCO – Excited to initiate a long-term position. Current levels offer a 50% discount from all-time highs, and the fundamentals + structure look aligned. Excited to document what human behavior reveals on the charts over time. Patience. Discipline. Execution. To The Moon & Beyond! 🫡 🌖

0 · Reply

JarvisFlow Aug. 1 at 2:11 PM

Morgan Stanley has updated their rating for Bausch & Lomb ( $BLCO ) to Equal-Weight with a price target of 13.

0 · Reply

ebu Aug. 1 at 2:21 AM

$BHC I can't think of any company where a stock split happened May 6th 2022. And it's shareholders are still waiting for 80% of $BLCO shares. Its unbelievable that 3 years and 3 months have past since then.

5 · Reply

JarvisFlow Jul. 31 at 3:40 PM

Wells Fargo has updated their rating for Bausch & Lomb ( $BLCO ) to Equal-Weight with a price target of 15.

0 · Reply

kbingo12 Jul. 30 at 2:19 PM

its amazing how poor performance continues at $BLCO and $BHC and management never changes.

0 · Reply

Market Cap	5.50B
Revenue (ttm)	4.79B
Net Income (ttm)	-317.00M
EPS (ttm)	N/A
PE Ratio	37.57
Forward PE	30.93
Profit Margin	-6.62%
Debt to Equity Ratio	0.76

Volume	310,348
Avg Vol	510,770
Day's Range	N/A - N/A
Shares Out	354.09M
Stochastic %K	65%
Beta	0.63
Analysts	Sell
Price Target	$15.14